Genomics Revolution Spurs Growth in $18.3 Billion PCR Technologies Market

The global market for polymerase chain reaction (PCR) technologies is projected to grow from $12.5 billion in 2021 to $18.3 billion by 2027, at an impressive compound annual growth rate (CAGR) of 8.0%. Several key factors are driving this robust market expansion.

Firstly, the rising incidence of infectious diseases, genetic disorders, and other targeted conditions is fueling demand for accurate and rapid diagnostic tools like PCR. Additionally, continued innovations in PCR technologies, along with increasing research funding and investments, are propelling the market forward. Moreover, the growing penetration of these technologies in emerging economies presents lucrative opportunities for market players.

However, the high costs associated with digital PCR (dPCR) instruments and certain technical limitations of quantitative PCR (qPCR) and dPCR are potential restraints on market growth during the forecast period.

Download a PDF brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96291811

Market Dynamics

On the demand side, increasing investments, funds, and grants for research and development (R&D) in genomics and personalized medicine are boosting the adoption of PCR technologies. Government agencies and private organizations worldwide are recognizing the crucial role of qPCR and dPCR products in genomics research, leading to substantial funding initiatives.

Conversely, the high costs of dPCR instruments, which can range from $55,000 to $120,000 in the US, may limit their demand, especially among smaller research organizations and companies.

Emerging Opportunities and Challenges

Emerging markets, particularly in Asia, offer significant growth opportunities for PCR technologies. Rising healthcare expenditures, expanding infrastructure, and increasing awareness about genomic diagnostics in these regions are driving demand. However, the adoption and implementation of guidelines like the Minimum Information for Publication of Quantitative Real-time PCR Experiments (MIQE) remain a challenge, as they involve laborious preparation and considerations.

Market Segmentation

The reagents and consumables segment accounted for the largest share of the PCR technologies market in 2021, driven by the expanding applications of dPCR, increasing analytical procedures, and the rising availability of novel dPCR reagents worldwide.

The qPCR segment held the largest share by technique in 2021, owing to factors such as automation, growing adoption among researchers and healthcare professionals, and increased funding for qPCR-based research.

Geographically, North America dominated the market in 2021, while the Asia-Pacific region is expected to witness the highest CAGR during the forecast period, driven by healthcare infrastructure modernization, increasing penetration of cutting-edge diagnostics, and growing awareness about gene-based disease diagnosis and treatment.

Prominent players in the PCR technologies market include Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad Laboratories, QIAGEN, Takara Bio, Agilent Technologies, bioMérieux, Fluidigm Corporation, Danaher Corporation, Abbott Laboratories, Merck KGaA, Becton Dickinson and Company, Promega Corporation, Eppendorf AG, and Analytik Jena AG.

In conclusion, the PCR technologies market is poised for substantial growth, driven by increasing disease prevalence, technological advancements, and expanding applications in emerging economies. While challenges exist, the market's prospects remain promising, fueled by continuous innovation and growing demand for accurate and efficient diagnostic tools. 

Comments

Post a Comment

Popular posts from this blog

From Pain Management to Drug Delivery: The Rising Trajectory of Transdermal Patches

Image
The global transdermal patches market is poised for significant expansion in the coming years, projected to grow from $6.2 billion in 2023 to $8.0 billion by 2029 at a compound annual growth rate (CAGR) of 4.5%. This burgeoning market is driven by several key factors, including the rising prevalence of chronic diseases, the increasing adoption of analgesic patches, technological advancements in transdermal patch development, and a shift away from traditional injections toward more convenient and patient-friendly transdermal delivery systems. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=190809043 One of the primary driving forces behind this growth is the growing popularity of analgesic patches for pain management. These patches offer a localized and controlled release of painkillers through the skin, reducing the risk of systemic adverse effects associated with oral medications. Patients with chronic pain disorders are increasingly turning to anal...
Read more

Introducing the Future of Beauty: Cutting-Edge Medical Aesthetics Treatments

Image
Introduction to Medical Aesthetics: Medical aesthetics is a field of medicine that focuses on improving the appearance of the body through various treatments, such as laser treatments, chemical peels, injectables, and fillers. It is a combination of medical and cosmetic treatments, which are designed to enhance a patient’s natural beauty, while also addressing any health concerns a patient may have. Medical aesthetics has become increasingly popular in recent years, as more people seek to improve their appearance and overall health. The benefits of medical aesthetics treatments are numerous. Patients can achieve a more youthful and vibrant look, improve skin tone and texture, reduce wrinkles and fine lines, correct discoloration and sun damage, and even out skin tone. Additionally, medical aesthetic treatments can help with body contouring and scarring, as well as providing a boost to self-confidence. The results of medical aesthetic treatments can last for many months or even yea...
Read more

Scaffold Products Lead Tissue Engineering Market Growth, Driven by Orthopedic Applications

The global tissue engineering market is projected to expand from $4.4 billion in 2023 to $8.9 billion by 2028, representing a strong CAGR of 15.3%. Key growth drivers include the rising need for advanced regenerative medicines to treat chronic and degenerative diseases, as well as increasing incidence of traumatic injuries from accidents. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=34135173 While high treatment costs currently restrain market growth, exciting technological advancements like 3D bioprinting, organ-on-chip technology, and Quantum Magnetic Resonance Therapy (QMRT) present attractive future growth opportunities. Traditional organ transplants remain a more cost-effective alternative currently and are a challenge the industry must overcome. The tissue engineering ecosystem involves hospitals, clinics, technology providers, regulatory bodies, and collaborative networks all working together to advance tissue engineering solutions. Sca...
Read more